title: Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin.
abstract: Pharmaceutical agents directed against methicillin-resistant Staphylococcus aureus can be eliminated during haemodiafiltration, not only by diffusion and ultrafiltration, but also by adsorption onto haemofilters. The latter may be affected by the binding of agents to serum albumin. The present study therefore investigated the affinity of anti-methicillin-resistant Staphylococcus aureus agents (teicoplanin, linezolid, vancomycin) for haemofilters and the pharmacokinetic properties of teicoplanin during haemodiafiltration. Linezolid, teicoplanin and vancomycin were first screened for their in vitro affinity for three different kinds of filter membranes: polysulfone, polyacrylonitrile and polymethylmethacrylate. Only teicoplanin showed significant filter-binding activity. An in vitro haemodiafiltration circulation model was then developed that incorporated a one-litre beaker containing Krebs-Ringer's bicarbonate solution with/without human albumin (0 or 3 g/dl) as an artificial plasma. Teicoplanin (initial concentration 50 µg/ml, representing the maximum plasma concentration (Cmax) resulting from a typical clinical dosage) was circulated throughout the beaker. Teicoplanin concentrations in the 'plasma' and ultrafiltrate were determined by high performance liquid chromatography. In the screening experiment, teicoplanin was predominantly adsorbed onto polysulfone and polymethylmethacrylate membranes. Furthermore, teicoplanin was primarily eliminated by adsorption onto these filters during in vitro haemodiafiltration. Albumin significantly reduced both haemodiafiltration clearance and the adsorption-dependent elimination, although there were complex but significant interactions between albumin and the filter membrane. Elimination of teicoplanin in an in vitro haemodiafiltration model was largely due to adsorption onto polysulfone and polymethylmethacrylate haemofilters. Future clinical studies should likely be designed to evaluate present recommendations of teicoplanin dosages in patients on haemodiafiltration.
authors.affiliation: Department of Emergency Medical Science, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Shiraishi
authors.forename: M
authors.initials: M
authors.lastname: Okajima
authors.forename: Y
authors.initials: Y
authors.lastname: Sai
authors.forename: K
authors.initials: K
authors.lastname: Miyamoto
authors.forename: H
authors.initials: H
authors.lastname: Inaba
mesh_terms: D000081:Acetamides / Q000302:isolation & purification / Q000493:pharmacokinetics*; D000327:Adsorption; D000418:Albumins / Q000737:chemistry; D000465:Algorithms; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D005374:Filtration; D017583:Hemodiafiltration / Q000379:methods*; D006801:Humans; D000069349:Linezolid; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D008954:Models, Biological; D023303:Oxazolidinones / Q000302:isolation & purification / Q000493:pharmacokinetics*; D013203:Staphylococcal Infections / Q000382:microbiology; D017334:Teicoplanin / Q000302:isolation & purification / Q000493:pharmacokinetics*; D014640:Vancomycin / Q000302:isolation & purification / Q000493:pharmacokinetics*
chemical_list: D000081:Acetamides; D000418:Albumins; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D017334:Teicoplanin; D014640:Vancomycin; D000069349:Linezolid